| Filed On | Filing |
|---|---|
| 14 Feb 2020 | SC 13G/A |
| 12 Feb 2020 | SCHEDULE 13G/A |
| 07 Feb 2020 | SC 13G/A |
| 06 Feb 2020 | SC 13G/A |
| 03 Feb 2020 | 15-12B |
| 27 Jan 2020 |
Form 4: Jindal Piyush, Director
Returned 1,070 shares to the issuer |
| 27 Jan 2020 |
Form 4: Compton-Phillips Amy, Director
Returned 1,512 shares to the issuer |
| 27 Jan 2020 |
Form 4: Asher Andrew Lynn, EVP, Chief Financial Officer
Returned 68,782 shares to the issuer |
| 27 Jan 2020 |
Form 4: Meyer Michael Troy, Chief Accounting Officer
Returned 5,516 shares to the issuer |
| 27 Jan 2020 |
Form 4: Michael Yount, EVP, Chief of Staff & CCO
Returned 11,039 shares to the issuer |
| 27 Jan 2020 |
Form 4: Radu Michael P, EVP, Quality and Pharmacy
Acquired 26,885 shares (Disposition to Issuer) |
| 27 Jan 2020 |
Form 4: Hakim Anat, EVP, General Counsel/Secretary
Returned 10,515 shares to the issuer |
| 27 Jan 2020 |
Form 4: Munson Kelly A, EVP, Medicaid
Returned 25,137 shares to the issuer |
| 27 Jan 2020 |
Form 4: Leenay Mark, EVP, Chief Medical Officer
Returned 6,060 shares to the issuer |
| 27 Jan 2020 |
Form 4: Polen Michael Robert, EVP, Medicare and Operations
Returned 26,900 shares to the issuer |
| 27 Jan 2020 |
Form 4: Trodden Timothy, EVP, Chief HR Officer
Returned 4,997 shares to the issuer |
| 27 Jan 2020 |
Form 4: Mims Rhonda R., EVP, Chief Public Affairs Offi
Returned 5,979 shares to the issuer |
| 27 Jan 2020 |
Form 4: Burdick Kenneth A, Director
Acquired 247,644 shares (Disposition to Issuer) |
| 27 Jan 2020 |
Form 4: Walsh Kathleen E, Director
Returned 1,512 shares to the issuer |
| 27 Jan 2020 |
Form 4: Trubeck William L, Director
Returned 24,065 shares to the issuer |
Loading...